Zhitong Finance App News, Huabang Health (002004.SZ) issued an announcement. Chongqing Huabang Pharmaceutical Co., Ltd. (hereinafter referred to as “Huabang Pharmaceutical”), a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for ibutinib tablets approved and issued by the State Drug Administration. Ibutinib tablets are declared according to the 3 types of chemicals, which is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs. The official approval of this product will further enrich the company's product pipeline layout in the field of anti-cancer, while providing clinical patients with more high-quality medication options.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.